Library

4B-MAR

First definitively identified in Austria in January 2022 and sold online as racemic trans-diastereomer (approximately 90% assay purity). No peer-reviewed pharmacodynamic studies yet exist; structure-activity relationships and subjective reports suggest potency slightly lower than 4-methylaminorex but still active at sub-25 mg doses. User reports from Bluelight and research forums indicate threshold effects at 2-4 mg insufflated and functional amphetamine-like stimulation around 15-25 mg with 12-18 hour wakefulness but modest euphoria. Analytical characterization confirms bromine isotopic LC-HRMS signature (m/z 255.0133 [M+H]+) and chiral separation reveals racemic trans-diastereomer form. Purity differences between batches (85-98%) warn of potential inactive filler or active by-products.

Also known as: 4'-br-4-mar, 4-bromo aminorex, Para‑bromo‑4‑methylaminorex, P‑bromo‑4‑methylaminorex, 4‑bromo‑4‑methylaminorex

Classification

  • Chemical: Aminorex
  • Psychoactive: Stimulant
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Increased Perspiration
  • Teeth Grinding
  • Pupil Dilation
  • Jaw Tension
  • Coldness
  • Focus Enhancement
  • Motivation Enhancement
  • Analysis Enhancement
  • Wakefulness
  • Time Distortion
  • Anxiety
  • Appetite Suppression
  • Light Sensitivity
  • Increased Libido
  • Dehydration
  • Bodily Control Enhancement
  • Increased Music Appreciation

Routes of Administration

Oral / Sublingual

Dosage

  • Threshold: 2-5 mg
  • Light: 5-15 mg
  • Common: 15-25 mg
  • Strong: 25-40 mg
  • Heavy: 40 mg

Duration

  • Onset: 0.33-1 h
  • Comeup: 0.5-1.5 h
  • Peak: 2-4 h
  • Offset: 4-6 h
  • After Effects: 6-24 h

Insufflated

Dosage

  • Threshold: 2 mg
  • Light: 2 mg - 10 mg
  • Common: 10 mg - 25 mg
  • Strong: 25 mg - 40 mg
  • Heavy: 40+ mg

Duration

  • Onset: 0.17-0.5 h
  • Comeup: 0.33-0.75 h
  • Peak: 1.5-3 h
  • Offset: 4-6 h
  • After Effects: 6-24 h
  • Total Duration: 8-14 h

Vaporized / Smoked

Dosage

  • Threshold: 1 mg
  • Light: 1-5 mg
  • Common: 5-15 mg
  • Strong: 15-25 mg
  • Heavy: 25 mg

Duration

  • Onset: 0.02-0.08 h
  • Comeup: 0.08-0.25 h
  • Peak: 2-4 h
  • Offset: 3-5 h
  • After Effects: 6-24 h

Oral

Dosage

  • Heavy: 60+ mg
  • Light: 5 mg - 15 mg
  • Common: 15 mg - 40 mg
  • Strong: 40 mg - 60 mg
  • Threshold: 5 mg

Duration

  • Onset: 0.33-1 h
  • Peak: 2-4 h
  • Offset: 6-10 h
  • After Effects: 6-24 h
  • Total Duration: 10-16 h

Sublingual

Dosage

  • Heavy: 55+ mg
  • Light: 5 mg - 15 mg
  • Common: 15 mg - 35 mg
  • Strong: 35 mg - 55 mg
  • Threshold: 5 mg

Duration

No data available for this section yet.

Vaporized

Dosage

  • Heavy: 30+ mg
  • Light: 1 mg - 5 mg
  • Common: 5 mg - 15 mg
  • Strong: 15 mg - 30 mg
  • Threshold: 1 mg

Duration

  • Onset: 0.05-0.08 h
  • Peak: 0.5-2 h
  • Offset: 4-8 h
  • After Effects: 6-24 h
  • Total Duration: 8-14 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

4B-MAR - Guide des substances DrugsPRO

4B-MAR: First definitively identified in Austria in January 2022 and sold online as racemic trans-diastereomer (approximately 90% assay purity). No peer-reviewed pharmacodynamic studies yet exist; structure-activity relationships and subjective reports suggest potency slightly lower than 4-methylami

Related pages